While GSM models alone are quite useful for determining the metabolic potential of an organism, determination of the metabolic phenotype under various stress conditions requires the incorporation of additional information, such as transcriptomic data, which for now at least, are the most comprehensive, and genomically complete sets of genomic data that can be acquired.
The increasing number of sequenced prokaryotic genomes contains a wealth of genomic data that needs to be effectively analysed.
It is fortunate that Beijing Genomics Institute (BGI) and the International Rice Genome Sequencing Project have released their rice genomic data that provide comparative basis for a thorough analysis on MS between indica and japonica subspecies.
However, it has also been pointed out by the Chimpanzee Genome Sequencing and Analysis Consortium [ 14] while comparing chimpanzee and human genomic data that "Insertion and deletion (indel) events are fewer in number than single-nucleotide substitutions, but result in ~1.5% of the euchromatic sequence in each species being lineage-specific".
Their findings provide further support that whole-genome analysis of even small amounts of fcDNA can provide high-quality, validated genomic data that strengthen the potential of the usefulness of the methylation signature of fcDNA in clinical applications.
These results provide further support that whole-genome analysis of even small amounts of fcDNA can provide high-quality, validated genomic data that strengthen the potential of fcDNA utility in clinical applications.
"The limitation for most people is how to make sense of the genomic data that is generated," he says.
However, compared to the tremendous amount of genomic data that is available, epigenomic data is relatively sparse and biased, which is an obstacle to answer the question conclusively.
Reese, S. E. et al. A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis.
The challenge now is how to interpret and derive biological knowledge from the massive quantities of genomic data that are now being produced.
Without greater diversity in the genomic data that is collected, he notes that we cannot fully reap the benefits of this knowledge, particularly in areas such as healthcare.
